Cargando…
Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
Background: We developed a fluorophore-conjugated peptide agent, SBK4, that detects a tumor-specific proteolyzed form of the cell adhesion molecule, PTPmu, found in the tumor microenvironment. We previously demonstrated its tissue specific distribution in high-grade brain tumors. To extend those stu...
Autores principales: | Vincent, Jason, Craig, Sonya E. L., Johansen, Mette L., Narla, Jyosthna, Avril, Stefanie, DiFeo, Analisa, Brady-Kalnay, Susann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911696/ https://www.ncbi.nlm.nih.gov/pubmed/33513911 http://dx.doi.org/10.3390/diagnostics11020181 |
Ejemplares similares
-
A PTPmu Biomarker is Associated with Increased Survival in Gliomas
por: Johansen, Mette L., et al.
Publicado: (2019) -
Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents
por: Johansen, Mette L., et al.
Publicado: (2021) -
Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth
por: Molyneaux, Kathleen, et al.
Publicado: (2023) -
Artificial Intelligence-Based Computational Screening and Functional Assays Identify Candidate Small Molecule Antagonists of PTPmu-Dependent Adhesion
por: Molyneaux, Kathleen, et al.
Publicado: (2023) -
A novel binding pocket in the D2 domain of protein tyrosine phosphatase mu (PTPmu) guides AI screen to identify small molecules that modulate tumour cell adhesion, growth and migration
por: Molyneaux, Kathleen, et al.
Publicado: (2023)